US 9233103
Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy
granted A61KA61K31/4365A61K31/44
Quick answer
US patent 9233103 (Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy) held by Takeda Pharmaceuticals U.S.A., Inc. expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceuticals U.S.A., Inc.
- Grant date
- Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/4365, A61K31/44, A61K31/4439, A61P